News

May 23, 2012 — Edwards Lifesciences Corp. announced that data from its post-approval study involving 94 European centers performing transcatheter aortic valve replacement (TAVR) demonstrated...

May 21, 2012 -- Boston Scientific Corp. announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus Aortic Valve System in patients with severe...

May 15, 2012 — In a keynote Founders’ Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Session on May 10, Ted Feldman, M.D., FSCAI, highlighted how...

May 4, 2012 - Edwards Lifesciences Corp. announced that new data from the European multi-center Triton trial studying the Edwards Intuity valve system highlights the promise of several important...

May 4, 2012 - SMT Research & Development Ltd. (SMT) announced the addition of three key executives to its management team, including a new CEO, CFO and chief medical officer, plus two...

May 1, 2012 – The Centers for Medicare and Medicaid Services (CMS) announced today it will now cover transcatheter aortic valve replacement (TAVR) for Medicare patients under certain conditions....

April 23, 2012 - Boston Scientific Corp. announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System...

April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scientific meeting, May 17, in Paris.

April 19, 2012 - St. Jude Medical Inc., a global medical device company, announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and the launch of the Trifecta...

April 12, 2012 - Edwards Lifesciences Corp. said a U.S. Food and Drug Administration (FDA) advisory panel will review the company's request to expand the indication for the Sapien transcatheter...

April 4, 2012 — Edwards Lifesciences Corp. reported that longer-term results (≥ 2 years) from the high-risk Cohort A of the PARTNER Trial – a randomized comparison of patients treated with either...

Patients who underwent transcatheter aortic valve implantation (TAVI) at experienced medical centers had significant improvement in valve function as well as low mortality and stroke rates at 30...

March 29, 2012 — Non-cardiac co-morbidities such as chronic obstructive pulmonary disease, chronic kidney disease and frailty are the main predictors of late mortality after transcatheter aortic...

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...

GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College...

March 8, 2012 — Edwards Lifesciences Corp. reported March 3 it filed its official response to the Centers for Medicare and Medicaid Services (CMS) on its proposed national coverage determination (...

March 7, 2012 — Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial recommendations for creating and maintaining transcatheter aortic valve...

February 20, 2012 — Edwards Lifesciences Corp. announced that it received CE mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (...

February 16, 2012 — Siemens Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for syngo Aortic ValveGuide, an integrated image processing software that helps...

February 3, 2012 — Colibri Heart Valve received an notification it received patents for a new transcatheter heart valve from the United States Patent and Trademark Office.